Role of Exenatide in NASH-a Pilot Study

NCT00650546 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Nonalcoholic Fatty Liver Disease

Interventions

DRUG: Exenatide

Sponsor

Indiana University

Collaborators

[object Object]